The Rising Intravenous (IV) Ibuprofen Market Is Driven By Increased Adoption of Pain Management Therapies
The intravenous (IV) ibuprofen market has witnessed an increase in demand due to its advantages over oral drugs. IV ibuprofen products provide quick relief to patients suffering from acute pain resulting from medical or surgical procedures through direct administration into the bloodstream.
The global intravenous (IV) ibuprofen market is estimated to be valued at US$ 11.13 Bn in 2024 and is...
0 Comments
0 Shares
86 Views
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek